Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1988 Aug 20;297(6647):511–514. doi: 10.1136/bmj.297.6647.511

Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.

J F Robertson 1, J H Todd 1, I O Ellis 1, C W Elston 1, R W Blamey 1
PMCID: PMC1840371  PMID: 3139179

Abstract

STUDY OBJECTIVE--Comparison of tamoxifen and mastectomy in treatment of breast cancer in elderly patients. DESIGN--Randomised trial of treatment of operable breast cancer by wedge mastectomy or tamoxifen, with median follow up 24 and 25 months respectively (range 1-63). SETTING--University hospital; most patients from primary catchment area. PATIENTS--135 consecutive patients with breast cancer aged over 70 with operable tumours (less than 5 cm maximum diameter); 68 were allocated to tamoxifen group and 67 to mastectomy group. Histological diagnosis by biopsy. Two incorrect randomisations in each group. Patient characteristics similar in the two groups and all under care of one surgical team. INTERVENTIONS--Mastectomy group received wedge mastectomy plus excision of symptomatic axillary lymph nodes. Tamoxifen group received continuous treatment with tamoxifen 20 mg twice daily. Patients in tamoxifen group received wedge mastectomy if there was sign of local progression. Those in mastectomy group received further excision or radiotherapy for locoregional recurrence and when local treatments had been exhausted or metastatic disease diagnosed they received tamoxifen. END POINT--Treatment efficacy was assessed by local control of disease and by survival. MAIN RESULTS--Mortality from metastatic cancer in tamoxifen group was 7 (10.6%) and in mastectomy group 10 (15.3%) (NS). There was no difference in survival between the two groups. In mastectomy group 70% remained alive and free of local recurrence at 24 months; in tamoxifen group only 47% remained alive and free of local progression. In mastectomy group locoregional recurrence occurred in 16 patients and metastatic disease in 13; in tamoxifen group locoregional progression occurred in 29 patients and metastatic disease in seven. CONCLUSIONS--As a high proportion of patients treated with tamoxifen eventually required surgery treatment of elderly patients with breast cancer should include mastectomy. Optimum treatment may include both mastectomy and tamoxifen.

Full text

PDF
511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan S. G., Rodger A., Smyth J. F., Leonard R. C., Chetty U., Forrest A. P. Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J (Clin Res Ed) 1985 Feb 2;290(6465):358–358. doi: 10.1136/bmj.290.6465.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bradbeer J. W., Kyngdon J. Primary treatment of breast cancer in elderly women with Tamoxifen. Clin Oncol. 1983 Mar;9(1):31–34. [PubMed] [Google Scholar]
  3. Elston C. W. The assessment of histological differentiation in breast cancer. Aust N Z J Surg. 1984 Feb;54(1):11–15. doi: 10.1111/j.1445-2197.1984.tb06677.x. [DOI] [PubMed] [Google Scholar]
  4. Herbsman H., Feldman J., Seldera J., Gardner B., Alfonso A. E. Survival following breast cancer surgery in the elderly. Cancer. 1981 May 15;47(10):2358–2363. doi: 10.1002/1097-0142(19810515)47:10<2358::aid-cncr2820471006>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  5. Hopkinson G. B., Bullen B. R. Removable subcuticular skin suture in acute appendicitis: a prospective comparative clinical trial. Br Med J (Clin Res Ed) 1982 Mar 20;284(6319):869–869. doi: 10.1136/bmj.284.6319.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Preece P. E., Wood R. A., Mackie C. R., Cuschieri A. Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study. Br Med J (Clin Res Ed) 1982 Mar 20;284(6319):869–870. doi: 10.1136/bmj.284.6319.869-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Todd J. H., Dowle C., Williams M. R., Elston C. W., Ellis I. O., Hinton C. P., Blamey R. W., Haybittle J. L. Confirmation of a prognostic index in primary breast cancer. Br J Cancer. 1987 Oct;56(4):489–492. doi: 10.1038/bjc.1987.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Williams M. R., Gilson D., Marsh L., Morgan D. A., Nicholson R. I., Elston C. W., Griffiths K., Blamey R. W. The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer. Eur J Surg Oncol. 1988 Jun;14(3):235–240. [PubMed] [Google Scholar]
  9. Williams M. R., Hinton C. P., Todd J. H., Morgan D. A., Elston C. W., Blamey R. W. The prediction of local or regional recurrence after simple mastectomy for operable breast cancer. Br J Surg. 1985 Sep;72(9):721–723. doi: 10.1002/bjs.1800720917. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES